25 Sep 2019
Fonterra sells DFE Pharma for $633m
Fonterra is selling its profitable 50 percent stake in DFE Pharma for $633-million, which will help it reduce debt, but will also hit its bottomline.
Recent stories from Business News
Get the RNZ app
for easy access to all your favourite programmes
